Dark Mode
Wednesday, 16 April 2025
Logo
Warning from the U.S. Food and Drug Administration About Fake Copies
أدوية (أرشيف)

On Monday, the U.S. Food and Drug Administration (FDA) warned consumers and pharmacies about the presence of counterfeit versions of the drug "Ozempic," which is used to treat type 2 diabetes, in the U.S. markets.

The agency clarified that these counterfeit products have entered the market through unlicensed distributors or vendors, raising concerns about patient safety. It added that it is working in collaboration with the drug's manufacturer, Novo Nordisk, to examine these products to determine whether they are safe for use.

In the United States, patients wishing to obtain "Ozempic" are required to present a valid prescription to licensed pharmacies, which are responsible for verifying the products for any signs of counterfeiting.

"Ozempic" is a glucagon-like peptide-1 receptor agonist aimed primarily at improving blood sugar control in adults with type 2 diabetes, as well as reducing the risk of major cardiovascular diseases.

"Ozempic" has also gained worldwide popularity as a weight-loss tool, with its manufacturer reporting nearly $17 billion in sales for the drug in 2024, according to a report by UPI news agency. The current warnings come at a time when the demand for this medication is increasing, highlighting the urgent need for quality monitoring and regulatory compliance in the pharmaceutical market.

Caricature

BENEFIT AGM approves 10%...

ads

Newsletter

Subscribe to our mailing list to get the new updates!